In view of these findings, study authors reportedly called on doctors to cease the use of MoM hip implants. Study author Ashley Blom from the University of Bristol also added that patients who do not require total hip replacement have no reason to take the risk of undergoing the procedure, especially with various alternative treatment options in place. The government-funded study was published online in The Lancet in March 2012.
Additionally, MoM hip devices have been associated with elevated levels of potentially toxic metals in a patient’s blood, according to online media reports. In a safety communication released by the US Food and Drug Administration in January 2013, the federal agency raised the alarm over the propensity of all-metal devices to release minute metal particles at the site where two components connect.
As this occurs, metal debris may accumulate in tissues and bones surrounding the implant, rendering recipients susceptible to pain, inflammation, and soft tissue damage. These metal ions may also be distributed through a patient’s bloodstream, bringing about systemic reactions or illnesses elsewhere in the body. Moreover, such adverse event may also cause a hip device to come loose, precipitating dislocation or even premature implant failure.
A large number of MoM hip implant recipients who may have undergone a revision surgery due to early hip device failure have started filing lawsuits against various hip replacement device makers in the US. Relevant information regarding these hip replacement lawsuits and other concerns involving hip replacement implants are also featured on some personal injury law firm sites.
0 comments:
Post a Comment